Long-term Low-Molecular-Weight Heparin versus Usual Care in Proximal-Vein Thrombosis Patients with Cancer
Top Cited Papers
- 1 December 2006
- journal article
- research article
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 119 (12), 1062-1072
- https://doi.org/10.1016/j.amjmed.2006.02.022
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Randomized Comparison of Low Molecular Weight Heparin and Coumarin Derivatives on the Survival of Patients With Cancer and Venous ThromboembolismJournal of Clinical Oncology, 2005
- Low-Molecular-Weight Heparin in the Treatment of Patients with Venous ThromboembolismNew England Journal of Medicine, 1997
- Heparin for 5 Days as Compared with 10 Days in the Initial Treatment of Proximal Venous ThrombosisNew England Journal of Medicine, 1990
- Detection of Deep-Vein Thrombosis by Real-Time B-Mode UltrasonographyNew England Journal of Medicine, 1989
- Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1986
- The diagnosis of acute, recurrent, deep-vein thrombosis: a diagnostic challenge.Circulation, 1983
- Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1982
- Adjusted Subcutaneous Heparin versus Warfarin Sodium in the Long-Term Treatment of Venous ThrombosisNew England Journal of Medicine, 1982
- Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous ThrombosisNew England Journal of Medicine, 1979
- Pulmonary angiography in acute pulmonary embolism: Indications, techniques, and results in 367 patientsAmerican Heart Journal, 1971